[Clinical considerations on a recent preparation with bronchial secretolytic action].
D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011656:Pulmonary Emphysema / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D014050:Toluene / Q000627:therapeutic use*
D000814:Aniline Compounds; D000996:Antitussive Agents; D005100:Expectorants; D014050:Toluene
Considerazioni cliniche su di un recente preparato ad azione secretolitica bronchiale.